glp 1 for kidney disease Mechanisms of GLP-1 receptor–independent renoprotective effects of the dipeptidyl peptidase type 4 inhibitor linagliptin in GLP-1 receptor knockout mice with 5/6 nephrectomy Kidney Outcomes With Glucagon-Like Peptide-1
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 177.Drummond R.F., Seif K.E., Reece E.A
Saxenda: The generic name is liraglutide
The ESSENCE trial will provide valuable data on the maintenance of histological benefits over 240 weeks of continuous treatment, but long-term extension studies and off-treatment follow-up protocols are needed to characterize rebound kinetics
[DOI] [PubMed] [Google Scholar] 2.CDC [Internet]
But it does suggest that: Only a small fraction of NENs may even have the docking station (the GLP-1 receptor) that these drugs can act on
As researcher Dr
